Family Name *
First Name *
Primary Profession *
Area of practice *
Institute *
Department *
E-mail address (MANDATORY TO RECEIVE CERTIFICATE WITH CME CREDITS) *
City *
Postal Code
Country *
Phone
Mobile
Fax
Address
Programme Evaluation
In order to receive your certificate of attendance and CME credits, you are kindly required
to provide the information below. Please, take a few minutes to complete this form. We are
interested in your opinions about this educational activity
1. Overall, how satisfied are you with this program? *
At the end of the congress, the attendess will be able:
- To promote research, education and clinical practice in endocrinology for the public benefit *
- to provide novel information on endocrine disorders and environmental factors, from latest insights to future development and prevention *
- to promote occasions for exchange experiences and network with endocrinologists across Europe *
- to recognize the importance of Rare disease and the problems that patients experience *
- to gain information on metabolic disorders, from science to everyday clinical practice *
- to recognize the comorbidities associated with the most frequent endocrine disorders *
2. Please indicate how you feel about the following statements concerning this programme:
a) The programme met the stated educational objectives *
b) Have I learned something from this event *
c) The quality of the content was appropriate *
d) The quality of the speakers was appropriate *
e) The event was well organised *
f) The location/venue was appropriate for the event *
g) The program staff was courteous *
3. How likely are you to recommend the European Congress of Endocrinology to a friend?
Please tell us why you have given this score
4. This programme was free of commercial bias *
If no, please describe the bias:
5. The information provided in this programme will ultimately benefit patient care? *
Please explain:
6. How would you improve this programme?
7. Please tick the top three (3) reasons why you decided to attend this programme? *
8. What topics, speakers, etc. would you like to see in future programmes?
9. How did you first learn about this programme? *
10. If you are involved with other scientific meetings, how likely would you be to recommend Bioscientifica for your event management?
11. Please tell us why you have given this score
Demographics
12. What is your primary profession? (Please choose the one area that best fits you.) *
13. How many years have you been active in your primary profession? *
14. What is your primary role? (Please choose the one area that best fits you.) *
15. Personal data that you supplied, by consent, could be used also to send you information about EXCEMED
activities. Would you like to receive updates on our programmes? *
PLEASE EVALUATE THE FOLLOWING SESSIONS:
Saturday, May 3, 2014
ECE 2014 Opening Ceremony
Please rate this session's Relevance of Content.
Saturday, May 3, 2014
Geoffrey Harris Prize Lecture
Please rate this session's Relevance of Content.
Saturday, May 3, 2014
European Journal of Endocrinology Prize Lecture
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Plenary Lecture 1 - Genes, environment and endocrine disease
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Presidents' Address
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Symposium 1: Endocrine changes and treatment needs in critically ill patients
- Thyroid dysfunction in critically ill patients: to treat or not to treat?
- Adrenal dysfunction in critically ill patients
- Treatment of diabetes in critically ill patients: rationale and glycemic target
Symposium 2: Pituitary development – from basic research to clinical practice
- Stem/progenitor cells in the pituitary
- Gonadotrope plasticity at cellular and population levels
- Management of adult patients with disorders of pituitary development
Symposium 3: News from thyroid hormones: central transport, energy control and oxidative stress
- Neuro-glial functional coupling in deiodination mediated thyroid hormone signaling
- Novel aspects of thyroid hormone transport in the brain
- Oxidative damage due to macromolecules in the thyroid gland – experimental evidence
Symposium 4: Endocrine Nurses Session 1: Craniopharyngioma
- Challenges in the management of patients with Craniopharyngioma
- The role of the Endocrine Nurse in the long-term care and treatment of patients post diagnosis of Craniopharyngioma
- Psychological aspects of living with a pituitary-related condition
Symposium 5: Obesity Beyond BMI
- Expandability of adipose tissue and clinical implications
- Relevance of body composition analysis
- Are metabolically healthy obese individuals really healthy?
Sunday, May 4, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Symposium 6: Focus on novel developments of PCOS
- Etiopathogenesis of PCOS
- Diagnosis of PCOS
- Treatment of PCOS
Symposium 7: Nontumorous pituitary diseases
- New developments in Autoimmune hypophysitis
- Unusual pituitary infections
- Tuberculosis of the pituitary gland
Symposium 8: Membrane lipid composition and receptor function. Signalling and trafficking
- Membrane lipid composition and receptor function
- Spatiotemporal control of endocytosis by membrane lipids
- Membrane dynamics in physiology and disease
Symposium 9: EYES Session - Cold metabolic inflammation in obesity: ignored complication and treatment target?
- Introduction EYES
- Fertility - PCOS: Metformin
- CVD - Atheroslcerosis: nanomedicine
Sunday, May 4, 2014
Plenary Lecture 2 - Advances in molecular pathogenesis of thyroid cancer – therapeutic implications
Please rate this session's Relevance of Content.
Sunday, May 4, 2014
Plenary Lecture 3 - Good times, bad times: (patho) physiology of diurnal rhythms
Please rate this session's Relevance of Content.
Monday, May 5, 2014
Symposium 10: Difficulties in the treatemnt of Graves' orbitopathy
- New therapeutic approach
- Radiotherapy in Graves' orbitopathy - when? how? what for?
- When should we perform orbital decompression?
Symposium 11: Long term outcome of “cured” pituitary patients
- Acromegaly
- Quality of life in patients with Non-functioning pituitary adenoma
- Craniopharyngeoma
Symposium 12: Gut microbiota in diabetes and obesity
- The gut microbiota and links to metabolic pathologies
- Fecal transplantation
- Functional interactions between diet, microbiota and host: effects on intestinal architecture and host nutrient absorption.
Symposium 13: Androgen excess in women and PCOS: conclusions from the PCOS Task Force
- Laboratory investigation of androgens
- PCOS vs non-classic forms of 21 hydroxylase deficiency
- Androgen secreting tumors and hyperthecosis
- Severe insulin resistant states and PCOS
- PCOS and cardiometabolic issues
Endocrine Nurse Session 3: Meet the Nurse Expert - Management of Endocrine Emergencies
- Meet the Nurse Expert: Management of hypoadrenalism and adrenal crisis
- Case presentation of a patient with adrenal crisis
- Meet the Nurse Expert: Management and treatment of the patient presenting with symptoms of thyrotoxicosis
- Case presentation of a patient with thyrotoxicosis
Monday, May 5, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Monday, May 5, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Monday, May 5, 2014
Symposium 14: Clinical outcome of medical intervention in Disorder of Sex Development (DSD)
- European study on disorder of sex development
- Consequences of the preservation of under developed testes in adulthood
- Hormones responsiveness in germ cells neoplasm
Symposium 15: Thromboembolism and contraception
- Epidemiology of sex steroid related thromboembolism
- The view of the Hematologist on thromboembolism
- The view of the Gynecologist on thromboembolism
Symposium 16: Metformin: old dog, new tricks
- Novel mechanisms mediating metformin actions: implications for diabetes and cancer
- Mechanism of antitumoral activity of metformin in thyroid cancer
- Antitumoral effects of metformin on cancer stem cells: identification of novel molecular targets
Symposium 17: Cushing’s syndrome
- Is mortality in cured Cushing’s increased or not?
- Paediatric Cushing’s
- The place of medical therapy in Cushing’s syndrome
Tuesday, May 6, 2014
Plenary Lecture 4: Islet transplantation
Please rate this session's Relevance of Content.
Tuesday, May 6, 2014
UEMS presentation
Please rate this session's Relevance of Content.
Tuesday, May 6, 2014
Symposium 18: Endocrine disease during pregnancy
- Pituitary tumours during pregnancy
- Pheochtomocytromas/ paragangliomas during pregnancy
- Congenital adrenal hyperplasia during pregnancy
Symposium 19: Osteoporosis - An update
- Paediatric osteoporosis
- Denosumab: current perspectives
- Atypical fractures and bisphosphonates in osteoporosis
Symposium 20: New hormones and endocrine tissues
- FGF21, irisin, and other novel players in endocrine metabolic regulation
- Products of the ghrelin gene, their role in regulating beta cell and adipocyte function
- The gut: a key organ coordinating the brain control of energy homeostasis
Symposium 21: Dilemmas in hormonal replacements
- Can we offer androgens in males with a history of prostate cancer?
- Can we offer oestrogen replacement therapy in women with breast cancer?
- Can we offer GH replacement to patients with a history of malignancy?
Tuesday, May 6, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Tuesday, May 6, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Tuesday, May 6, 2014
Symposium 22: Novel therapies for thyroid cancer
- Clinical trials and approved drugs
- Limits of targeted therapies and future developments
- Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
Symposium 23: Neuroendocrine tumours
- Molecular pathogenesis of neuroendocrine tumours
- Therapeutic approaches models
- Systemic therapeutic options
Symposium 24: Nutrient regulation of metabolism and endocrine systems
- Using low-carbohydrate/high fat diets todisect macronutrient effects on endocrine systems
- Metabolic Consequences of a High Fat Diet on Mouse Models of Growth Hormone Action
- The role of FTO in the brain response to different macronutrients
Symposium 25: Gonadal hormones and obesity
- Oestrogens and body weight
- PCOS and obesity: unveiling the basic links
- Perinatal androgen exposure and body weight fate
Tuesday, May 6, 2014
Plenary Lecture 5 - Simultaneous treatment of menopausal symptoms and prevention of breast cancer: Is it possible?
Please rate this session's Relevance of Content.
Wednesday, May 7, 2014
Plenary Lecture 6 - Hypothalamic inflammation - cause or consequence of obesity?
Please rate this session's Relevance of Content.
Wednesday, May 7, 2014
Symposium 26: Pitfalls in hormone measurement
- Guidelines on GH/IGF-1 measurement
- Pitfalls in thyroid function tests
- Advantages of mass spectrometry in the measurement of steroid hormones
Symposium 27: Brown Adipose Tissue
- White, brown and pink: plasticity of adipocytes
- Hunting human brown fat by imaging
- Brown adipose tissue: the wholy grail of metabolic disease
Symposium 28: Molecular pathophysiology for clinicians: receptor-related disorders
- Disorders related to G-protein receptors
- Disorders related to nuclear receptors
- Disorders related to calcium-sensing receptor signalling
Symposium 29: Obesity prevention and treatment
- Mediterranean diet in the prevention of cardiovascular disease
- Rare primary and secondary genetic events in T2D and obesity
- Is healthy diet regulated by our genes?
Wednesday, May 7, 2014
Debate 4: Mild primary hyperparalthyroidism surgery or not?
Please rate this session's Relevance of Content.
Wednesday, May 7, 2014
Please check and evaluate the session attended
Please rate this session's Relevance of Content.
Wednesday, May 7, 2014
Plenary Lecture 7 - Reproduction and energy metabolism, an ancestral balance to be preserved for women's health
Please rate this session's Relevance of Content.
Informative Document ex. Art. 13, Legislative Decree n. 196, 30 June 2003 (Italian Privacy Protection Law)
In compliance with the article 13 of Legislative Decree n. 196, 30 June 2003, we hereby give you the following information:
1. Personal data will be processed, with or without the use of electronic or automated means, via suitable tools that will guarantee security and confidentiality;
2. Personal data from you supplied will be communicated to Continuing Medical Education Accreditation Authorities, to agencies that will take care of the whole accreditation process and agencies that will take care of the logistics of the event; should we not receive the above requested data, we will not be able to process the assignment of your CME credits.
3. At anytime you may exercise your rights as laid down in the art. 7 of Legislative Decree n. 196, 30 June 2003 of the Italian Law, by contacting the Data Controller EXCEMED (Salita San Nicola da Tolentino 1/B – 00187 - Rome - Italy) in the person of Data Processor, Michele Piraux.